Back to Trades
Sell4
CHEVRON CORP
CVX
Total Value
$23.5M
Net $8.6M sold
Sales
$8.6M
5 transactions
Company Information
- Company Name
- CHEVRON CORP
- Ticker Symbol
- CVX
- CIK
- 0000093410
Insider Information
- Name
- BONNER EIMEAR P
- Role
- Chief Financial Officer
- Location
- HOUSTON, TX
Officer
Filing Details
- Filing Date
- Mar 3, 2026
- Transaction Date
- Feb 27, 2026
- Accession Number
- 0000093410-26-000082
- Form Type
- 4
- Net Trading Amount
- -$8.6M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | 18,800 | $152.35 | Exercise | $2.9M |
| Feb 27, 2026 | Common Stock | 9,600 | $153.22 | Exercise | $1.5M |
| Feb 27, 2026 | Common Stock | 5,500 | $184.28 | Sale | $1.0M |
| Feb 27, 2026 | Common Stock | 2,500 | $185.33 | Sale | $463.3K |
| Feb 27, 2026 | Common Stock | 18,100 | $186.56 | Sale | $3.4M |
| Feb 27, 2026 | Common Stock | 2,300 | $187.16 | Sale | $430.5K |
| Mar 2, 2026 | Common Stock | 17,400 | $179.08 | Exercise | $3.1M |
| Mar 2, 2026 | Common Stock | 17,400 | $190.60 | Sale | $3.3M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Derivative | 18,800 | $152.35 | Exercise | $2.9M |
| Feb 27, 2026 | Derivative | 9,600 | $153.22 | Exercise | $1.5M |
| Mar 2, 2026 | Derivative | 17,400 | $179.08 | Exercise | $3.1M |
Footnotes
- (F1)The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2025.
- (F2)This number includes rounding of fractional shares.
- (F3)This transaction was executed in multiple trades at prices ranging from $183.85 to $184.82, inclusive. The price reported in Column 4 reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form.
- (F4)These shares were sold in multiple transactions at prices ranging from $184.85 to $185.83, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- (F5)These shares were sold in multiple transactions at prices ranging from $185.87 to $186.85, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- (F6)These shares were sold in multiple transactions at prices ranging from $186.95 to $187.43, inclusive. The price reported in Column 4 reflects the weighted average sale price.
- (F7)Option granted 2/6/2024. One-third of the shares subject to the option vested on February 10, 2025 and February 10, 2026, respectively, and one-third of the shares will vest on February 10, 2027.
- (F8)Option granted 2/4/2025. One-third of the shares subject to the option vested on February 10, 2026 and one-third of the shares will vest on February 10, 2027 and February 10, 2028, respectively.
- (F9)Option granted 1/25/2023. One-third of the shares subject to the option vested on January 31, 2024, January 31, 2025 and January 31, 2026, respectively.